SCHEMBL4559627

SCHEMBL4559627

Cc1ncsc1C(=O)NCc1ccc(F)cc1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.60
L3MBTL1 Q9Y468 2/20 0.60
VHL P40337 1/20 0.51
MAPT P10636 2/20 0.50
HTT P42858 1/20 0.49
SCD O00767 1/20 0.48
CHRM4 P08173 1/20 0.48
PPARA Q07869 1/20 0.47
LMNA P02545 3/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3048657 0.86 SMN1; SMN2 (0.59) SMN1; SMN2L3MBTL1VHLSCDCHRM4
SCHEMBL4030640 0.85 SMN1; SMN2 (0.54) SMN1; SMN2L3MBTL1VHLSCDCHRM4
SCHEMBL4205317 0.82 HSD17B13 (0.60) SMN1; SMN2L3MBTL1CHRM4KMT2AHPGD
SCHEMBL4025840 0.82 CHRM4 (0.53) SMN1; SMN2L3MBTL1CHRM4KMT2AKDM4E
SCHEMBL4362487 0.80 L3MBTL1 (0.54) SMN1; SMN2L3MBTL1VHLMAPTCHRM4
SCHEMBL11536219 0.78 CXCR4 (0.64) SMN1; SMN2L3MBTL1MAPTHTTSCD
SCHEMBL3369612 0.77 KMT2A (0.56) MAPTCHRM4LMNAKMT2AALDH1A1
SCHEMBL244641 0.77 SCD (0.58) SMN1; SMN2L3MBTL1MAPTHTTSCD
SCHEMBL3042709 0.76 CHRM4 (0.57) SMN1; SMN2L3MBTL1MAPTHTTSCD
SCHEMBL3454547 0.76 SCD (0.57) SMN1; SMN2L3MBTL1MAPTHTTSCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054408-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL Novartis Ag (CH) 2009-05-06 EP disclosed
WO-2008127349-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL NOVARTIS AG (CH) 2008-10-23 WO disclosed